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A rapid and sensitive method based on ultrafast liquid chromatography–tandem mass spectrometry was
developed and validated for simultaneous determination of Sudan I, Sudan II, Sudan III, and Sudan IV
levels in rat whole blood. Cleanert C18 mixed-mode polymeric sorbent was used for effective solid-phase
extraction cleanup. Separation was carried out on a reversed-phase C18 column (100 mm2.1 mm,
1.8 μm) using 0.1% (v/v) formic acid in water/0.1% (v/v) formic acid in acetonitrile as the mobile phase in
gradient elution. Quantiﬁcation was performed by an electrospray ionization source in the positive
multiple reaction monitoring mode using D5-Sudan I as the internal standard. Calibration curves showed
good linearity between 0.2 and 20.0 μg/L, with correlation coefﬁcients higher than 0.9990. The average
recovery rates were between 93.05% and 114.98%. The intra- and inter-day relative standard deviations
were within 6.2%. The lower limit of quantiﬁcation was 0.2 μg/L. All the analytes were found to be stable
in a series of stability studies. The proposed method was successfully applied to a pharmacokinetic study
of four Sudan dyes after oral administration to rats.
& 2015 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Sudan dyes (Sudan I, Sudan II, Sudan III, and Sudan IV; Fig. 1), a
group of synthetic fat-soluble colorants that contain an azo group
(–N¼N–) as part of the structure, are mainly used in textile, rub-
ber, plastic, paint, and other coloring applications. Sudan dyes are
frequently used as a food-coloring agent by unscrupulous mer-
chants because of their bright red color, colorfastness, and low
price. However, these synthetic colorants have been classiﬁed as
possible human carcinogens [1–4], and pose a potential risk to
consumer health if their daily intake exceeds the maximally per-
mitted levels established by the World Health Organization [5].
Thus, their extensive use in food products has been prohibited by
the European Commission [6].
Several analytical methods have been used to determine the
presence of Sudan dyes in food products. These methods mainly
involve liquid chromatography (LC) [7–11], ﬂow injection chemi-
luminescence [12], enzyme-linked immunosorbent assays [13–15],on and hosting by Elsevier B.V. All
University.
x: þ86 574 87085078.capillary electrophoresis [16], electrochemical methods [17,18],
LC–mass spectrometry (MS) [10,19–21], and electrospray tandem
quadrupole orthogonal-acceleration time-of-ﬂight MS [22–25]. LC
separation, most commonly used method, has been coupled with
different spectrophotometric detection methods to determine the
Sudan dye levels. These detections include MS [10,19–25], ultra-
violet/visible detection [7,8,10,11], diode array detection [9], and
electrochemical detection [12]. However, relatively few studies
have analyzed azo dye residues in whole blood samples [26]. With
the development of electrospray ionization (ESI), MS has become a
powerful analytical tool in pharmaceutical analysis because of its
high sensitivity, selectivity, and short run time [27–31]. In com-
bination with LC, tandem MS (MS/MS) is a superior alternative for
drug residue analysis in biological samples. The aim of this study
was to develop a sensitive, robust, and fast method for the analysis
of low-level concentrations of four azo dyes (Sudan I, Sudan II,
Sudan III, and Sudan IV) in whole blood samples using ultrafast LC
with MS/MS (UFLC–MS/MS). The proposed method can achieve
rapid separation of dyes in gradient elution within 6.5 min. The
validated method was applied to determine the levels of the four
Sudan analytes in rat whole blood samples obtained from healthy
Sprague-Dawley (SD) rats used in pharmacokinetic studies.rights reserved. This is an open access article under the CC BY-NC-ND license
Fig. 1. Chemical structures of Sudan I, Sudan II, Sudan III, and Sudan IV.
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2.1. Chemicals and materials
Sudan I (495.0%), Sudan II (499.0%), Sudan III (498.0%), and
Sudan IV (498.0%) were purchased from Dr. Ehrenstorfer GmbH
(Augsburg, Germany) and used without further puriﬁcation. D5-
Sudan I (purity499.4%) was purchased from Witega Laboratories
Berlin–Aldershof GmbH (Berlin, Germany). High-performance LC
(HPLC)-grade acetonitrile and n-hexane were purchased from
Merck (Darmstadt, Germany). HPLC-grade formic acid was ob-
tained from Sigma-Aldrich (St. Louis, MO, USA). The solid-phase
extraction (SPE) Cleanert C18 cartridges (500 mg/6 mL) used for
sample preparation were procured from Agela Technologies
(Tianjin, China). HPLC-grade water was generated using a Milli-Q
integral water puriﬁcation system (Millipore, Molsheim, France).
Edible oil was obtained from the local market (Ningbo, China).
Blank blood was obtained from untreated animals and frozen at –
20 °C until analysis.
2.2. Animals
Certiﬁed commercial SD rats, weighing 240720 g, were pur-
chased from the Experimental Animal Center of the Zhejiang
Academy of Medical Sciences (Hangzhou, Zhejiang, China). Thirty
healthy and drug-free SD rats (15 males and 15 females) were
acclimatized in 10 rat cages in a unidirectional airﬂow room with
controlled temperature (22–25 °C), relative humidity (45%–55%),
and a 12 h light/dark cycle for one week before the start of the
experiments. The rats were given free access to ﬁltered tap water
and commercial rat food.
2.3. Apparatus and conditions
UFLC–MS/MS was performed using a Shimadzu Prominence
UFLC XR system coupled with an Applied Biosystems SCIEX Triple
Quad 5500 mass spectrometer and ESI source. The UFLC–MS/MS
system was controlled, and data were analyzed on a computerequipped with Analyst 1.5.1 (Applied Biosystems, MA, USA).
Chromatographic separation was performed on an Agilent Eclipse
Plus C18 column (column size: 2.1 mm100 mm, particle size:
1.8 μm) using solution A (water with 0.1% (v/v) formic acid) and
solution B (acetonitrile with 0.1% (v/v) formic acid) as the mobile
phase. The ﬂow rate was 0.45 mL/min. The gradient program used
for elution was as follows: initial conditions with solvent B were
increased from 10% B to 95% B in 2.0 min, held constant at 95% B
for 2.5 min, returned to initial conditions, and maintained for
2.0 min for equilibration. The total run time was 6.5 min. The
column temperature was set at 40 °C. A total of 5 mL of the solution
was injected into the UFLC–MS/MS system for analysis.
MS was performed using the positive ESI mode and multiple
reaction monitoring (MRM) mode for quantiﬁcation. The opti-
mized instrument operating parameters for mass spectral acqui-
sition were as follows: ion spray voltage, 5500 V; curtain gas,
40 psi; interface heater, on; nebulizer gas (gas 1) and heater gas
(gas 2), 30 psi each; turbo spray temperature, 500 °C; entrance
potential, 10 V; and collision cell exit potential, 10 V. Nitrogen was
used in all cases. Retention times, precursor ions (Q1), product
ions (Q3), declustering potential (DP), and collision energies (CEs)
of each Sudan dye are shown in Table 1. The dwell time was set at
0.05 s for all the compounds.
2.4. Standard stock solution preparation
Individual stock solutions of four Sudan dyes and D5-Sudan I as
an internal standard (IS) at 1000.0 mg/L were prepared in acet-
onitrile. The standard solution was stored at –20 °C in tightly
closed bottles in the dark. Mixed standard stock solution was
prepared by diluting the standard stock solution of each dye with
acetonitrile to a ﬁnal concentration of 100.0 μg/L. The IS solution
was subsequently diluted with acetonitrile to a ﬁnal concentration
of 100.0 μg/L. Working standard solutions at the concentrations of
0.2, 0.5, 1.0, 2.0, 5.0, 10.0, and 20.0 μg/L were prepared daily by
diluting the mixed standard stock solution with acetonitrile in
appropriate proportions.
2.5. Calibration standards and quality control (QC) samples
Calibration standard solutions at the concentrations of 0.2, 0.5,
1.0, 2.0, 5.0, 10.0, and 20.0 μg/L were freshly prepared by adding
the appropriate mixed standard stock solution (100.0 μg/L) to
20.0 μL of blank rat whole blood, and stored at 4 °C until the in-
itiation of UFLC–MS/MS analysis (IS concentration: 2.0 μg/L). The
four concentration levels (0.2, 0.5, 5.0, and 16.0 μg/L) (lower limit
of quantitation (LLOQ), low, medium, and high levels) in blank rat
whole blood were considered as QC samples. These samples were
stored in a freezer compartment at 20 °C and brought to room
temperature before use.
2.6. Sample preparation
Approximately 20.0 μL of whole blood sample and 10.0 μL of IS
solution (100.0 μg/L) were mixed in a 2.0 mL Eppendorf tube, in
which 0.5 mL of acetonitrile was added prior to extraction. The
mixture was extracted by vortex-mixing for 3 min at ambient
temperature. The extract was centrifuged at 20,000g for 5 min. The
supernatant solution was then subjected to SPE for further
puriﬁcation.
The Cleanert C18 cartridges were preconditioned and equili-
brated with 2 mL of methanol and 2 mL of water. Then, the
aforementioned mixed solution was slowly loaded into the
Table 1
Q1/Q3 ion pairs, DP, CE of MRM, and retention time for the optimized UFLC–MS/MS method in MRM mode.
Compounds Retention
time (min)
Precursor ion
(Q1, m/z)
Product ion
(Q3, m/z)
DP
(V)
CE
(eV)
Sudan I 3.31 249.1 93.0a, 128.0,
156.0
50 38, 38, 21
Sudan II 3.87 277.1 121.2a,
156.0, 260.0
70 27, 20, 17
Sudan III 3.26; 4.26 353.1 77.0a, 119.9,
156.0
80 50, 31, 31
Sudan IV 3.65; 5.19 381.2 91.0a, 106.0,
224.0
100 33, 48, 29
D5-Sudan I 3.31 254.1 98.0a, 156.0,
128.0
130 40, 22, 38
a Quantitative ion.
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were rinsed with 2 mL of acetonitrile/water (50:50, v/v) at a ﬂow
rate of 1 mL/min and pump-dried. Elution was performed with
two aliquots of 3 mL of n-hexane. The eluate was evaporated to
dryness by a gentle nitrogen ﬂow and reconstituted with 0.5 mL of
acetonitrile. Finally, the reconstituted eluate was ﬁltered through a
0.2 μm polytetraﬂuoroethene (PTFE) microporous ﬁlm, and 5.0 μL
was injected into the UFLC–MS/MS system.
2.7. Selectivity
Six individual rat whole blood samples obtained from different
sources were used to assess selectivity. Blood from each rat subject
was extracted and checked for peaks that can interfere with the
detection of the four Sudan dyes and IS in the rat whole blood
samples. The chromatographic peaks were conﬁrmed by compar-
ing the retention times (tR) and mass fragment ions with those of
reference standards.
2.8. Matrix effect (ME)
As suggested by Matuszewski et al. [26], a quantitative ap-
proach to assess absolute MEs was performed using a post-ex-
traction addition study, in which percent ME (ME%) is calculated.
In this study, the absolute ME was determined by comparing the
mean peak areas of QC samples spiked post-extraction (B) with
those of the standard solutions (A).ME% was determined using the
following equation: absolute ME (ME%)¼(B/A)100. The absolute
MEwas evaluated at four concentration levels (LLOQ, 0.2 μg/L; low,
0.5 μg/L; medium, 5.0 μg/L; and high, 16.0 μg/L) and three parallels.
2.9. Precision and accuracy
The four QC samples (LLOQ, 0.2 μg/L; low, 0.5 μg/L; medium,
5.0 μg/L; and high, 16.0 μg/L) were used to assess interday preci-
sion and accuracy, which were analyzed on at least three separate
runs. For intraday precision, six aliquots of each QC sample were
thawed to room temperature and analyzed within a day. For in-
terday precision, the tested experiments were done in triplicates
for each QC sample on eight separate days within a two-week
period. The relative standard deviations (RSD%) of the four Sudan
dyes in each QC concentration were then calculated.
Accuracy was expressed by the recovery rates, which were
assessed by comparing the mean peak area ratios from the rat
blood samples for standards spiked before extraction (C) with
those for standards spiked after extraction into the plasma extracts
(B). The recovery rates were calculated using the followingformula: recovery (%)¼(C/B)100 [26]. Experiments on the three
QC samples were performed in ﬁve replicates.2.10. Stability
Stability experiments were performed to evaluate analyte sta-
bility in rat whole blood extracted samples under different con-
ditions. The LLOQ, low, medium, and high-concentration QC
samples were analyzed in triplicates. Short-term stability was
tested by placing the QC samples at room temperature in an au-
tosampler for 2, 4, 8, and 12 h. Freeze–thaw stability was de-
termined by analyzing the samples for three cycles (from –20 °C to
room temperature). Long-term stability of the QC samples stored
at 20 °C was tested for 30 days. The stability experiments were
then evaluated by comparing the concentration obtained with the
standard values (the quantitative data of the freshly prepared QC
samples by used the instrument method), followed by calculation
of the deviations.2.11. Pharmacokinetic study
The study was conducted in accordance with the Ethical
Guidelines for Investigations in Laboratory Animals and ap-
proved by the Ethics Review Committee for Animal Experi-
mentation of the Ningbo University. Certiﬁed commercial SD
rats were used after growth for one week. Before the day of
administration, 30 rats were randomly assigned to ﬁve groups
(blank edible oil group, Sudan I group, Sudan II group, Sudan III
group, and Sudan IV group). Each group comprised three males
and three females. Rats fasted overnight but were allowed ac-
cess to water ad libitum. Sudan dyes (Sudan I, Sudan II, Sudan III,
and Sudan IV) were separately dissolved in 10 mg/mL of edible
oil and administered via a single oral (p.o.) dose of 50 mg/kg of
Sudan dyes. Approximately 20.0 μL of the whole blood sample
(at 10.0, 20.0, 30.0, and 40.0 min and 1.0, 1.5, 2.0, 3.0, 5.0, 7.0,
10.0, 15.0, and 24.0 h postdosing for Sudan I and Sudan II;
whereas 1.0, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 9.0, 11.0, 15.0, 20.0, 32.0,
and 48.0 h postdosing for Sudan III and Sudan IV) was collected
from the rat tail vein, poured into a 2 mL of heparinized cen-
trifuge tube containing 0.5 mL of acetonitrile, and immediately
vortex-mixed for 3 min. These samples were immediately cen-
trifuged and cleaned according to Section 2.6. The extracts were
stored in the dark at 4 °C prior to analysis.
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3.1. Sample preparation
In this study, an efﬁcient extraction solvent was selected using a
recovery test (at 1.0 μg/L) in a rat whole blood sample. Based on their
molecular structures and fat-soluble properties, various extraction
solvents, such as methanol, acetonitrile, dichloromethane, and n-
hexane, were chosen. After the extraction and total processing time
were comprehensively evaluated, a simple protein precipitation
method was proposed for extraction. Acetonitrile was selected as the
optimal protein precipitation solvent because of its good protein
precipitation efﬁciency and good extraction efﬁciency.
Given that Sudan dyes are fat-soluble compounds, normal
neutral alumina SPE cartridges are recommended for use inFig. 2. MRM chromatograms with SPE clea
Fig. 3. Representative MS/MS spectra obtained from Sudacleanup. The activity of alumina N was adjusted according to the
recoveries of standard solutions through the column because of
variations in the quality of different batches of alumina N. During
SPE cleanup, trace water in blood extracts signiﬁcantly affected the
recovery and precision. Thus, extracts should be dried with an-
hydrous sodium sulfate prior to sample loading. However, the
application of this step for water-enriched rat whole blood sam-
ples prior to preparation is highly difﬁcult. Therefore, we selected
a stable and simple C18 SPE cartridge for cleanup, and achieved
good recovery rates with all four dyes, in which 495% were un-
affected by trace water. Fig. 2 shows the MRM chromatograms
with and without SPE cleanup. Interference signiﬁcantly decreased
with the use of SPE cleanup compared with that without SPE
cleanup.nup (A) and without SPE cleanup (B).
n I (A), Sudan II (B), Sudan III (C), and Sudan IV (D).
Fig. 4. Typical chromatograms of (A) blank rat blood; (B) blank rat blood spiked with Sudan I, Sudan II, Sudan III, and Sudan IV at LLOQ of 0.2 μg/L and IS of 2.0 μg/L; (C) rat
blood sample obtained at 40 min and 5 h after a single oral administration of 50 mg/kg of Sudan I, Sudan II, Sudan III, Sudan IV, and IS (2.0 μg/L).
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The analytes have hydrophobic and lipophilic characteristics.
Thus, organic solvent-rich mobile phases are typically used for
their rapid elution and strong retention in reversed-phase chro-
matography. C18 columns from different manufacturers have beenused in previous studies, in which the most common column
length was 150 mm, but diameters and particles differed. In our
preliminary experiments, mixtures of deionized water with two
common HPLC organic modiﬁers (acetonitrile and methanol) were
used as the mobile phases. The ﬂow rate was 0.45 mL/min, and the
sample injection volume was 5 mL. Acetonitrile offered better peak
Table 2
Mean extraction recoveries and MEs of Sudan I, Sudan II, Sudan III, Sudan IV, and IS in SD rat whole blood samples (n¼6).
Compounds and spiked concentration
(μg/L)
Average peak areas (104) Absolute
MEs (B/A) (%)
Average extraction
recoveries (C/B) (%)
RSD (%)
Neat solution (A) Post-spiked (B) Pre-spiked (C)
0.5 Sudan I 6.22 6.07 5.96 97.59 98.19 5.47
Sudan II 8.90 8.03 8.00 90.22 99.63 7.61
Sudan III 2.47 2.27 2.61 91.90 114.98 4.48
Sudan IV 3.38 3.19 3.45 94.38 108.15 3.67
D5-Sudan I 4.09 4.07 3.94 99.51 96.81 4.12
5.0 Sudan I 61.3 55.0 59.8 89.72 108.73 2.57
Sudan II 89.3 82.0 76.3 91.38 93.05 5.84
Sudan III 22.2 22.1 21.8 99.55 98.64 4.63
Sudan IV 36.6 35.8 36.2 97.81 101.12 1.49
D5-Sudan I 43.1 39.6 39.1 91.88 98.74 3.85
16.0 Sudan I 208 190 199 91.35 104.74 3.87
Sudan II 302 290 276 96.03 95.17 2.59
Sudan III 75.4 76.2 71.4 101.06 93.70 3.70
Sudan IV 122 121 120 99.18 99.17 5.13
D5-Sudan I 139 126 131 90.65 103.97 2.40
Table 3
Intra-day and inter-day accuracy and precision values for the determination of the four analytes (n¼3 days, six replicates per day).
Compounds and spiked
concentration (μg/L)
Intra-day (n¼6) Inter-day (n¼6)
Measured
concentration (μg/L)
Relative
deviationa (%)
Precisionb
(%)
Measured
concentration (μg/L)
Relative
deviation (%)
Precision
(%)
Sudan I
0.5 0.50570.024 1.0 4.8 0.49170.019 1.8 3.8
5.0 5.1070.12 2.0 2.4 5.1670.07 3.2 1.3
16.0 16.1670.61 1.0 3.8 15.8970.24 0.69 1.5
Sudan II
0.5 0.51670.025 3.2 5.0 0.51370.012 2.6 2.4
5.0 5.2070.08 4.0 1.6 5.0770.09 1.4 1.9
16.0 16.3270.33 2.0 2.1 16.1070.60 0.63 3.8
Sudan III
0.5 0.51170.021 2.2 4.2 0.52170.020 4.2 4.0
5.0 5.1270.14 2.4 2.8 4.7870.11 4.4 2.2
16.0 16.2470.75 1.5 4.7 16.0970.69 0.56 4.3
Sudan IV
0.5 0.48770.031 2.6 6.2 0.49570.018 1.0 3.6
5.0 5.1970.19 3.8 3.8 5.2570.24 5.0 4.8
16.0 16.0870.47 0.5 2.9 16.2170.53 1.3 3.3
a Relative deviation was calculated by comparing the difference between the measured average concentration and the theorematic spiked concentration with the
theorematic spiked concentration.
b Precision was calculated by comparing the deviation of six replicates with the standard concentration.
Table 4
Regression equations, linear ranges, LODs, and LLOQs of the four analytes.
Compounds Regression equationa Correlation
coefﬁcient (r)
Linear
range
(μg/L)
LODb
(μg/L)
LLOQb
(μg/L)
Sudan I Y¼1.017Xþ0.2094 0.9998 0.2–20 0.06 0.2
Sudan II Y¼1.100Xþ0.1780 0.9992 0.2–20 0.06 0.2
Sudan III Y¼0.489Xþ0.0370 0.9996 0.2–20 0.06 0.2
Sudan IV Y¼1.003Xþ0.3678 0.9990 0.2–20 0.06 0.2
a Y represents the peak area ratios of the four analytes individually compared with IS (D5-Sudan I), and X represents the concentration ratios of the four analytes
individually compared with spiked IS (D5-Sudan I) (2.0 μg/L for all the samples).
b LODs and LLOQs of the injection solutions from rat whole blood samples, which were extracted with acetonitrile.
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azo dyes were weak acids (pKa (Sudan I&II)¼11.65) because an in-
termolecular hydrogen bond could be formed with the phenolichydroxyl groups. Thus, the effect of the mobile phase pH on the
chromatographic behavior of analytes was investigated by acid-
ifying the aqueous portion through the addition of different formic
Table 5
Stability assessment for Sudan I, Sudan II, Sudan III, and Sudan IV in SD rat whole blood samples (n¼3).
Compounds
and spiked
concentration
(μg/L)
Short-term stability (room temperature for 2, 4, 8, and 12 h) Freeze–thaw stability (3rd freeze–thaw cycles) Long-term stability
(–20 °C for 30 days)
Measured concentration (μg/L) Relative deviationa (%) Measured
concentration (μg/L)
Relative deviationa (%) Measured
concentration
(μg/L)
Deviation
(%)
2 h 4 h 8 h 12 h 2 h 4 h 8 h 12 h Cycle
1
Cycle
2
Cycle
3
Cycle
1
Cycle
2
Cycle
3
Sudan I
0.2 0.217 0.198 0.203 0.216 8.5 1.0 1.5 8.0 0.225 0.217 0.227 12.5 8.5 13.5 0.217 8.5
0.5 0.491 0.482 0.505 0.521 1.8 3.6 1.0 4.2 0.481 0.495 0.503 3.8 1.0 0.6 0.504 0.8
5.0 4.940 4.915 5.007 4.943 1.2 1.7 0.2 1.1 4.963 5.033 5.128 0.7 0.7 2.6 5.116 2.3
16.0 15.678 15.862 15.664 16.154 2.0 0.9 2.1 1.0 15.846 16.093 15.884 1.0 0.6 0.7 15.978 0.2
Sudan II
0.2 0.213 0.208 0.224 0.229 6.5 4.0 12.0 14.5 0.213 0.218 0.206 6.5 9.0 3.0 0.196 2.0
0.5 0.486 0.487 0.502 0.503 2.8 2.6 0.4 0.6 0.493 0.508 0.521 1.4 1.6 4.2 0.492 1.6
5.0 4.907 4.952 5.247 5.126 1.9 1.0 4.9 2.5 4.898 4.788 4.988 2.0 4.2 0.2 4.985 0.3
16.0 16.077 16.024 15.935 15.876 0.5 0.2 0.4 0.8 15.959 16.129 16.141 0.3 0.8 0.9 16.064 0.4
Sudan III
0.2 0.207 0.203 0.218 0.220 3.5 1.5 9.0 10.0 0.225 0.213 0.223 12.5 6.5 11.5 0.204 2.0
0.5 0.503 0.467 0.524 0.519 0.6 6.6 4.8 3.8 0.501 0.523 0.497 0.2 4.6 0.6 0.510 2.0
5.0 5.156 5.127 5.333 5.220 3.1 2.5 6.7 4.4 5.137 4.953 5.240 2.7 0.9 4.8 5.067 1.3
16.0 16.120 16.204 16.328 16.147 0.8 1.3 2.1 0.9 15.892 16.045 15.864 0.7 0.3 0.9 16.128 0.8
Sudan IV
0.2 0.216 0.213 0.227 0.227 8.0 6.5 13.5 13.5 0.211 0.224 0.199 5.5 12.0 0.5 0.189 5.5
0.5 0.497 0.483 0.499 0.501 0.6 3.4 0.2 0.2 0.513 0.485 0.522 2.6 3.0 4.4 0.503 0.6
5.0 5.260 5.042 5.286 5.153 5.2 0.8 5.7 3.1 5.104 5.134 5.068 2.1 2.7 1.4 5.194 3.9
16.0 15.885 15.962 16.229 16.133 0.7 0.3 1.4 0.8 16.108 16.024 16.064 0.7 0.2 0.4 16.165 1.0
a Relative deviations were calculated by comparing the difference between the measured concentration and the spiked concentration with the spiked concentration.
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Signiﬁcantly improved peak symmetry and signal response values
were obtained at the formic acid concentration of Z0.1%. Thus,
water with 0.1% (v/v) formic acid and acetonitrile with 0.1% (v/v)
formic acid were ﬁnally selected as the mobile phase for gradient
elution.
In this study, the ESI–MS/MS behavior of four Sudan dyes was
investigated in MRM mode. At a cone voltage of 25 V, the full-scan
ESI(þ)–MS spectra of the analytes showed only the protonated
molecule [MþH]þ , thereby conﬁrming the molecular mass. Under
ESI–MS/MS conditions, the product-ion mass spectra of Sudan
dyes showed a characteristic fragmentation pattern for all the
analytes, as shown in Fig. 3. The protonated form of each analyte
and IS, [MþH]þ ion, was the parent ion in the Q1 spectrum and
was used as the precursor ion to obtain the Q3 product ion spectra.
The most sensitive mass transition was monitored at m/z 249.1-
93.0 for Sudan I, m/z 277.1-121.2 for Sudan II, m/z 353.1-77.0 for
Sudan III,m/z 381.2-91.0 for Sudan IV, and m/z 254.1-98.0 for IS.
3.3. Photostability and “fast peaks” of Sudan III and Sudan IV
Previous studies reported the appearance of “fast-eluting”
peaks in the chromatograms of Sudan III and Sudan IV [10,11,19].
Given that these peaks eluted a few minutes before the main peak
of the compounds, they were called “fast peaks”, which were
proven by Mölder et al. [10] to be caused by photochemical iso-
mers via MS. This phenomenon could lead to about 10%–35%
quantitative errors for Sudan III and Sudan IV if lightning condi-
tions were not controlled. However, photo-induced isomerization
was reversible when the compounds were stored in the dark or
wrapped in aluminum foil for a sufﬁcient time.
A considerable increase in the peak area of isomers was ob-
served upon standing on the tray of the autosampler withoutprotection from light, which conﬁrmed the ﬁndings of Mölder
et al. (Fig. 4). The nature of “fast peaks” could not be avoided in
routine conditions. Thus, they were integrated together with the
normal peaks for analysis. Our results (see Section 3.4) showed
that the “fast peaks” did not affect the accuracy of the analysis
when all the peaks of one compound were integrated together,
and the RSD and accuracy were satisfactory.
3.4. Method validation
3.4.1. Selectivity
Selectivity is deﬁned as the ability of the bioanalytical method
to measure a substance unequivocally and to discriminate be-
tween the analyte(s) and other components that may be present
[32]. Under optimized UFLC–MS/MS conditions, the rapid method
yielded excellent selectivity and sensitivity for the analysis of Su-
dan I, Sudan II, Sudan III, Sudan IV, and IS in the blank whole blood
samples (Fig. 4). To demonstrate the selectivity of the method and
to screen for interfering substances, three replicate analyses of six
blank whole blood samples and blood spiked with the LLOQ were
extracted and injected for analysis using the developed UFLC–MS/
MS method. The representative chromatograms of a blank rat
blood sample and a blank rat blood sample spiked with four Sudan
dyes (0.2 μg/L) are shown in Fig. 4. No signiﬁcant interfering en-
dogenous peaks were observed at the retention times of the four
Sudan dyes. Thus, according to the guidelines for industrial bioa-
nalytical method validation (2001) [33], the method that we de-
veloped was selective.
3.4.2. ME
The details of the performedME experiment are summarized in
Table 2. The absolute MEs of the four compounds and IS ranged
from 89.72% to 101.06%. An absent or insigniﬁcant ME in the
Fig. 5. Mean blood concentration–time curves of Sudan I and Sudan II (A), and Sudan III and Sudan IV (B) in six SD rats after a single oral administration of 50 mg/kg of Sudan
dyes.
Table 6
Pharmacokinetic parameters after oral administration of four Sudan dyes (50 mg/kg) to rats (n¼6).
Parameters Compounds
Sudan I Sudan II Sudan III Sudan IV
Cmax (μg/L) 630.91 696.26 349.39 1304.61
Tmax (h) 0.6046 1.362 4.196 4.341
ka (h1) 3.9960 1.3930 0.4368 0.4395
ke (h1) 0.8277 0.3829 0.2899 0.2932
t1/2(ka) (h) 0.1734 0.4975 1.587 1.577
t1/2(ke) (h) 0.8374 1.8102 2.3909 2.3640
MRT0–1 (h) 1.208 2.611 3.449 3.411
AUC0–1 (μg h/L) 1150.03 2966.66 2706.37 10,013.91
Cmax: maximum blood concentration; Tmax: time to peak value; ka: absorption rate constant; ke: elimination rate constant; t1/2(ke): elimination half-life; t1/2(ka): elimination
half-life; MRT0–1: mean residence time from time zero to inﬁnity; and AUC0–1: area under the curve from time zero to inﬁnity.
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with the requirement of the guidelines for industry and bioana-
lytical method validation by the Food and Drug Administration
[33].
3.4.3. Precision and accuracy
The accuracy and precision results are shown in Tables 2 and 3,
respectively. The mean recovery rates for the four compounds
(n¼6) of the three concentrations ranged from 93.05% to 114.98%.
The intra-day RSDs for 0.5, 5.0, and 16.0 μg/L ranged from 1.6% to
6.2%, and their inter-day RSDs for 0.5, 5.0, and 16.0 μg/L ranged
from 1.3% to 4.8%. Thus, the repeatability and recovery of the assay
were within the acceptance limits of 715% at the tested con-
centration levels.
3.4.4. Linearity, limit of detection (LOD), and LLOQ
The calibration model was selected based on the analysis of the
data by linear regression with intercepts and 1/x2 weighting factor
by using the Least-Squares Reﬁnement method. The linear cali-
bration curves were plotted as the peak area ratio of the analyte to
IS (Y) versus the target-compound mass-concentration ratios of
the analyte to IS (X). Representative linear equations of the four
compounds in rat whole blood are listed in Table 4. Each standard
point in every calibration curve was back-calculated using its own
equation. The linearities of the calibration curves were between
0.2 and 20.0 μg/L, and the correlation coefﬁcients (r) of the four
compounds were Z0.999.
LODs were established based on signal-to-noise (S/N) ratio of 3,
whereas LLOQs were established based on an S/N ratio of 10. The
LODs for the four compounds in the injection solutions were es-
timated to be 0.06 μg/L. Based on the acceptable precision andaccuracy, the LLOQ was 0.2 μg/L in the injection solutions, as
shown in Table 4.
3.4.5. Stability
The results for freeze–thaw cycle stability and short-term sta-
bility under room temperature at 0.2, 0.5, 5.0, and 16.0 μg/L levels
of the four compounds in rat whole blood are shown in Table 5. No
signiﬁcant degradations (o14.5% for short-term stability under
room temperature, o13.5% for freeze–thaw cycle stability, and
o8.5% for long-term stability) were observed for the four com-
pounds. Results show that the four compounds were stable under
the investigated conditions because the measured concentrations
were within the acceptable limits (r15% of the nominal
concentrations).
3.5. Pharmacokinetic study
The method that we developed was successfully applied to the
pharmacokinetic study after a single oral administration of 50 mg/
kg Sudan I, Sudan II, Sudan III, and Sudan IV to SD rats. Mean blood
concentration–time proﬁles of Sudan I, Sudan II, Sudan III, and
Sudan IV are shown in Fig. 5. The major pharmacokinetic para-
meters of the four analytes were calculated using a non-com-
partment model using DAS 2.0 statistical software (Pharmacology
Institute of China), and the results are shown in Table 6. These
pharmacokinetic results demonstrated that Sudan I, Sudan II,
Sudan III, and Sudan IV reached the maximum point in the whole
blood drug concentration of rats at about 0.6046, 1.362, 4.196, and
4.341 h after oral administration, respectively. The whole blood
concentration decreased gradually with an elimination half-life
(t1/2) of 0.8374, 1.8102, 2.3909, and 2.364 h for Sudan I, Sudan II,
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(ka) of Sudan I, Sudan II, Sudan III, and Sudan IV were 3.996, 1.393,
0.4368, and 0.4395 h1, which were signiﬁcantly greater than
their elimination rate constants (ke) of 0.8277, 0.3829, 0.2899, and
0.2932 h1, respectively. The four Sudan dyes were easily ab-
sorbed and quickly accessible to the loop body of the SD rats. The
phenomenon of rapid absorption possibly involves the speciﬁc and
lipophilic chemical properties of the four Sudan dyes. Given the
double phospholipid compositions of the cell membrane of the rat,
the lipophilic Sudan dyes successfully and rapidly accessed the
organic body. These results were in accordance with the maximum
blood concentrations achieved at 630.91, 696.26, 349.39, and
1304.61 μg/L for Sudan I, Sudan II, Sudan III, and Sudan IV, re-
spectively. The areas under the concentration–time curve
(AUC0–1) of Sudan I, Sudan II, Sudan III, and Sudan IV were
1150.03, 2966.66, 2706.37, and 10,013.91 μg h/L, respectively,
which indicated the high bioavailability of the four analytes. The
successful application of the UFLC–MS/MS method to the phar-
macokinetic study of four Sudan dyes suggested its suitability and
sufﬁciency for use in pharmacokinetic studies.4. Conclusions
In this study, a sensitive and rapid UFLC–MS/MS method was
developed and validated for determination of Sudan I, Sudan II,
Sudan III, and Sudan IV levels in rat whole blood. The established
method was fast, precise, accurate, speciﬁc, reproducible, and
suitable for the pharmacokinetic study of Sudan I, Sudan II, Sudan
III, and Sudan IV. The validated method was sufﬁciently sensitive
with an LLOQ of 0.2 μg/L. Thus, the method successfully de-
termined the Sudan I, Sudan II, Sudan III, and Sudan IV levels,
which ranged from 0.2 μg/L to 20.0 μg/L. UFLC–MS/MS is suitable
for detailed assessment in pharmacokinetic, bioequivalence, and
bioavailability studies.Acknowledgments
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